Developments RMTG’s Cellgenic launches NK cell product line outside U.S. Regenerative Medical Technology Group (RMTG) (OTCID: RMTG) has announced that its Cellgenic division has launched a natural killer (NK) cell product line for permitted markets outside the U.S., with an initial... August 25, 2026